Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients – SEMINARS IN ARTHRITIS AND RHEUMATISM

López-Maraver, M; Serrano-Combarro, A; Atienza-Mateo, B; del Val, N; Casafont-Sole, I; Melero-Gonzalez, RB; Pérez-Linaza, A; Gutiérrez, JC; Mena-Vázquez, N; Vegas-Revenga, N; Domínguez-Casas, L; Martos, JL; Ginés, CAP; Morrondo, CD; Albaladejo, LP; Sánchez, RL; Canabal, MGM; Brandy-García, AM; Viejo, PL; Bonilla, G; Maiz-Alonso, O; Carrasco-Cubero, C; Bufort, MG; Moreno, M; Urruticoechea-Arana, A; Ordóñez-Palau, S; González-Montagut, C; Serret, EG; De Aberasturi, JRDJ; Morillo, FL; Rodríguez, TV; Carreira, PE; Madrigal, JMB; Ibáñez, BM; López, MR; Fernández-Díaz, C; Loricera, J; Ferraz-Amaro, I; Ferrer-Pargada, D; Castañeda, S; Blanco, R – 2024 – 10.1016/j.semarthrit.2024.152517